Stocktoria
Syndax Pharmaceuticals Inc SNDX
Syndax Pharmaceuticals Inc institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 7,906,765 | $162.3M | 9.05% |
| Point72 Asset Management, L.P. | 1,985,547 | $46.4M | 2.27% |
| D. E. Shaw & Co., Inc. | 1,601,896 | $37.4M | 1.83% |
| TWO SIGMA INVESTMENTS, LP | 1,579,596 | $36.9M | 1.81% |
| AQR CAPITAL MANAGEMENT LLC | 980,314 | $22.9M | 1.12% |
| CITADEL ADVISORS LLC | 767,542 | $17.9M | 0.88% |
| RENAISSANCE TECHNOLOGIES LLC | 498,200 | $11.6M | 0.57% |
| MILLENNIUM MANAGEMENT LLC | 199,524 | $4.7M | 0.23% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.